Venlafaxine aggravating interstitial A case

被引:0
作者
Wu, Xia [1 ]
Zhang, Lutao [2 ,3 ]
Wang, Chuanping [1 ]
机构
[1] Hebei Med Univ, Hosp 2, Dept Pharm, Shijiazhuang, Peoples R China
[2] Hebei Med Univ, Hosp 2, Pulm & Critial Care Med, Shijiazhuang, Peoples R China
[3] Hebei Med Univ, Hosp 2, 215 West Heping Rd, Shijiazhuang 050000, Hebei, Peoples R China
关键词
venlafaxine; selective serotonin and norepinephrine reuptake inhibitors; depression; interstitial pneumonia; Naranjo assessment scale; PNEUMONITIS;
D O I
10.5414/CP204459
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A 70-year-old male taking venlafaxine for depression developed interstitial pneumonia and was admitted with shortness of breath and dyspnea. A computed tomography (CT) chest scan showed diffuse multiple lung lesions in both lungs, suggesting interstitial changes with inflammation or exudation. Compared with the CT chest scan 1 month earlier, there were significant progresses and new findings. The clinical diagnosis was interstitial pneumonia with pulmonary infection. The patient had been treated with fluvoxamine 100 mg/day, duloxetine 60 mg/ day, venlafaxine 75 mg/day for depression over the past 4 months. The exacerbation of interstitial pneumonia was suspected to be related to venlafaxine. Wheezing improved slightly after discontinuation of venlafaxine and treatment in the respiratory ICU. However, the patient could not tolerate the ICU environment, therefore became agitated, irritable, and anxious. Finally the patient gave up treatment and was discharged. Three months after discharge, the patient died of sudden of interstitial pneumonia. A Naranjo assessment score of 3 was obtained, indicating a possible correlation between the patient's adverse drug reaction and the suspect drug.
引用
收藏
页码:83 / 88
页数:6
相关论文
共 12 条
  • [1] Hypersensitivity Pneumonitis Due to Venlafaxine
    Borderias Clau, Luis
    Marigil Gomez, Miguel Angel
    Val Adan, Pascual
    Marcen Letosa, Mariano
    Biescas Lopez, Rosa
    Garrapiz Lopez, Francisco J.
    [J]. ARCHIVOS DE BRONCONEUMOLOGIA, 2008, 44 (10): : 571 - 573
  • [2] Psychopharmacological properties and therapeutic profile of the antidepressant venlafaxine
    Coutens, Basile
    Yrondi, Antoine
    Rampon, Claire
    Guiard, Bruno P.
    [J]. PSYCHOPHARMACOLOGY, 2022, 239 (09) : 2735 - 2752
  • [3] Interstitial lung disease induced by fluoxetine: Systematic review of literature and analysis of Vigiaccess, Eudravigilance and a national pharmacovigilance database
    Deidda, Arianna
    Pisanu, Claudia
    Micheletto, Laura
    Bocchetta, Alberto
    Del Zompo, Maria
    Stochino, Maria Erminia
    [J]. PHARMACOLOGICAL RESEARCH, 2017, 120 : 294 - 301
  • [4] Drug-induced pneumonitis and heart failure simultaneously associated with venlafaxine
    Drent, M
    Singh, S
    Gorgels, APM
    Hansell, DM
    Bekers, O
    Nicholson, AG
    van Suylen, RJ
    du Bois, RM
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 167 (07) : 958 - 961
  • [5] Simultaneous interstitial pneumonitis and cardiomyopathy induced by venlafaxine
    Ferreira, Pedro Goncalo
    Costa, Susana
    Dias, Nuno
    Ferreira, Antonio Jorge
    Franco, Fatima
    [J]. JORNAL BRASILEIRO DE PNEUMOLOGIA, 2014, 40 (03) : 313 - 318
  • [6] Flora Arjan, 2018, Drug Saf Case Rep, V5, P5, DOI 10.1007/s40800-017-0070-z
  • [7] High Venlafaxine Serum Levels After Prior Fluoxetine Medication
    Gerbaulet, Marcel
    Engel, Alice
    Hiemke, Christoph
    Dahmen, Norbert
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2012, 32 (02) : 295 - 297
  • [8] A METHOD FOR ESTIMATING THE PROBABILITY OF ADVERSE DRUG-REACTIONS
    NARANJO, CA
    BUSTO, U
    SELLERS, EM
    SANDOR, P
    RUIZ, I
    ROBERTS, EA
    JANECEK, E
    DOMECQ, C
    GREENBLATT, DJ
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (02) : 239 - 245
  • [9] A Case of Venlafaxine-Induced Interstitial Lung Disease
    Oh, Serim
    Cha, Seung-Ick
    Kim, Hyera
    Kim, Minjung
    Choi, Sun Ha
    Seo, Hyewon
    Park, Tae-In
    [J]. TUBERCULOSIS AND RESPIRATORY DISEASES, 2014, 77 (02) : 81 - 84
  • [10] Venlafaxine-induced interstitial lung disease with COVID-19 pandemic-related depression
    Okazaki, Akihito
    Kita, Katsunao
    [J]. CLINICAL CASE REPORTS, 2022, 10 (06):